Glycopyrronium Bromide (International)

Note: In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A03AB02,R03BB06

CAS registry number (Chemical Abstracts Service)

0000596-51-0

Chemical Formula

C19-H28-Br-N-O3

Molecular Weight

398

Therapeutic Category

Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)

Chemical Names

1,1-dimetyl-3-hydroxypyrrolidinium bromide α-cyclopentylmandelate (WHO)

3-(α-Cyclopentylmandeloyloxy)-1,1-dimetylpyrrolidinium bromide (BAN)

3-Hydroxy-1,1-dimetylpyrrolidinium bromide α-cyclopentylmandelate (USP)

Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimetyl-, bromide (USP)

Foreign Names

• Glycopyrronii bromidum (Latin)
• Glycopyrroniumbromid (German)
• Glycopyrronium (bromure de) (French)
• Bromuro de glicopirronio (Spanish)

Generic Names

• Glycopyrrolate (OS: USAN)
• Glycopyrronium (OS: DCF)
• Glycopyrronium Bromide (OS: BAN, JAN)
• AHR 504 (IS)
• NVA 237 (IS)
• UNII-V92SO9WP2I (IS)
• Glycopyrrolate (PH: USP 41)
• Glycopyrronii bromidum (PH: Ph. Eur. 9)
• Glycopyrronium (bromure de) (PH: Ph. Eur. 9)
• Glycopyrronium bromide (PH: Ph. Eur. 9)
• Glycopyrronium Bromide (PH: BP 2018)
• Glycopyrroniumbromid (PH: Ph. Eur. 9)

Brand Names

• Bevespi [+ Formoterol]
  AstraZeneca, United States
• Cuvposa
  Merz, United States
• Enurev
  Ferrer Internacional, Spain; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Sweden; Novartis Europharm, Greece
• Glyco-P
  Klab, Thailand
• Glycopyrodyn
  Excelsior, Taiwan
• Glycopyrrolate
  Amneal Pharmaceuticals, United States; Appco Pharma, United States; Aurolife, United States; Concordia, United Kingdom; Dr. Reddy's, United States; Hikma, United States; Leading Pharma, United States; Luitpold Pharmaceuticals, United States; Natco, United States; Nexgen, United States; Par Pharmaceutical, United States; Rising, United States; Santos Biotech, United States; Somerset, United States; Sun Pharma, United States; Vintage, United States
• Glycopyrrolate [veterinary use]
  Cronus Pharma, United States
• Glycopyrrolate Omega
  Omega Laboratories, Canada
• Glycopyrrolate Sandoz
  Sandoz, Canada
• Glycopyrronium Bromide
  Accord Healthcare, United Kingdom; Colonis Pharma, United Kingdom; Concordia, United Kingdom; LENIS, Slovenia; Martindale, United Kingdom; Sanolabor, Slovenia
• Glycopyrronium Bromide and Neostigmine [+ Neostigmine]
  Concordia, United Kingdom; Martindale, United Kingdom
• Glycopyrronium Bromide and Neostigmine Metilsulfate Max [+ Neostigmine]
  Max Health, New Zealand
• Glycopyrronium Bromide Colonis
  Colonis, Malta
• Glycopyrronium Bromide Macarthys
  MaCarthys, Malta
• Glycopyrronium Bromide Martindale
  Martindale Pharmaceuticals, Cyprus
• Glycopyrronium Bromide Max
  Max Health, New Zealand
• Glycopyrroniumbromid Accord 200 μg/ml
  Accord Healthcare, Austria
• Glycostigmin [+ Neostigmin]
  Takeda, Finland
• Glykopyrroniumbromid Accord
  Accord Healthcare, Sweden
• Hospira Glycopyrrolate
  Pfizer, Australia
• Panthero
  Farmanova, Turkey
• Riarify [+ Beclometasone, + Formoterol]
  Chiesi Farmaceutici, Netherlands
• Robinul
  Aspen, New Zealand; Aspen Pharmacare, Australia; Biosyn, Germany; Casper Pharma, United States; Concordia, United Kingdom; Eumedica, Belgium; Meda, Denmark; Meda, Norway; Meda, Sweden; Pharmacare, South Africa
• Robinul 0.2mg
  Chiesi Pharmaceuticals, Austria; Eumedica, Luxembourg
• Robinul Forte
  Casper Pharma, United States
• Robinul V [veterinary use]
  Vetoquinol, France
• Robinul-Neostigmine [+ Neostigmine]
  Eumedica, Belgium; Eumedica, Luxembourg; Meda, Denmark; Meda, Norway; Meda, Sweden; Sintetica, Switzerland
• Robinul-V [veterinary use]
  Zoetis, United States
• Seebri
  Beijing Novartis Pharma Co., Ltd., China; Novartis, Argentina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Ireland; Novartis, Japan; Novartis, Lithuania; Novartis, Latvia; Novartis, Macedonia; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis Europharm, Cyprus; Novartis Europharm, Romania; Novartis Europharm, Tunisia; Novartis Farmaceutica, Spain; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Sunovion, United States; Novartis Singapore, Singapore
• Seebri 44 Mikrogramm
  Novartis Pharma, Germany
• Seebri 44mcg
  Novartis, Hungary; Novartis, Luxembourg; Novartis Europharm, Austria
• Seebri 50mcg
  Novartis, Israel; Novartis, Oman; Novartis Pharma, Switzerland
• Seebri Breezehaler
  Novartis, Estonia; Novartis, Indonesia; Novartis Pharma, Peru
• Sialanar
  BCM, Estonia; Proveca, United Kingdom; Proveca, Lithuania; Proveca, Sweden
• Sibry
  Novartis Pharma, Russian Federation
• Tovanor
  Gebro, Spain; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Greece
• Trimbow [+ Formoterol, + Beclometasone]
  Chiesi, Belgium; Chiesi, Germany; Chiesi, Denmark; Chiesi, Estonia; Chiesi, United Kingdom; Chiesi, Norway; Chiesi, Romania; Chiesi, Slovakia; Chiesi Farmaceutici, Sweden; Chiesi Farmaceutici S.p.A., Greece; Chiesi Pharma, Finland; Chiesi Pharmaceuticals, Netherlands
• Trimbow 87μg/5μg/9μg [+ Formoterol, + Beclometasone]
  Chiesi Farmaceutici, Austria
• Trydonis [+ Beclomethasone, + Formoterol]
  Chiesi Pharmaceuticals, Netherlands
• Ultibro [+ Glycopyrronium Bromide]
  Novartis, Denmark
• Ultibro [+ Indacaterol]
  Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, Czech Republic; Novartis, Estonia; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Japan; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis Europharm, Greece; Novartis Europharm, Romania; Novartis Europharm, Slovenia; Novartis Europharm Limited, Latvia; Novartis Farmaceutica, Spain; Novartis Pharma, Peru; Novartis PHarma Services Inc., Serbia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom; Novartis Singapore, Singapore
• Ultibro 110/50 [+ Indacaterol]
  Novartis Pharmaceuticals, Australia
• Ultibro 110mcg/50mcg [+ Indacaterol]
  Novartis, Oman; Novartis Pharma, Switzerland
• Ultibro 85 µg/43 µg [+ Indacaterol]
  Novartis, Hungary; Novartis Europharm, Austria
• Ultibro 85 Mikrogramm/43 Mikrogramm [+ Indacaterol]
  Novartis Pharma, Germany
• Ulunar [+ Indacaterol]
  Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Sweden; Novartis Europharm, Greece; Rovi, Spain; Sanfer, Mexico; UCB Pharma, Germany
• Utibron [+ Indacaterol]
  Sunovion, United States
• Vagolate
  AHPL, India
• Xoterna [+ Indacaterol]
  Ferrer Internacional, Spain; Gador, Argentina; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Greece

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer